<?xml version="1.0" encoding="UTF-8"?>
<ref id="B19">
 <label>19.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Zhang</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Li</surname>
    <given-names>L</given-names>
   </name>, 
   <name name-style="western">
    <surname>Shen</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Chen</surname>
    <given-names>Y</given-names>
   </name>, 
   <name name-style="western">
    <surname>Qi</surname>
    <given-names>Z</given-names>
   </name>
  </person-group>
  <year>2020</year>
  <article-title>Rational use of tocilizumab in the treatment of novel coronavirus pneumonia</article-title>. 
  <source>Clin Drug Investig</source>
  <volume>40</volume>:
  <fpage>511</fpage>â€“
  <lpage>518</lpage>. doi:
  <pub-id pub-id-type="doi">10.1007/s40261-020-00917-3</pub-id>.
 </mixed-citation>
</ref>
